Cue Biopharma, Inc.

Historical 13F Holders

Symbol
CUE
CUSIP
22978P106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 22978P106 since 12/18/2024, largest first.

Filer % of Class Filed
Bleichroeder LP 13G/A
8.8% 11/10/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Mark E. Strome 13G/A
4.99% 5/16/2025
Event 11/14/2022
Slate Path Capital LP 13G/A
1.4% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 1 100 $55
2026 Q1 56 21.4 M $4.95M
2025 Q4 49 21.8 M $6.67M
2025 Q3 52 18.1 M $13.0M
2025 Q2 48 17.4 M $11.9M
2025 Q1 51 11.4 M $10.4M
2024 Q4 57 11.8 M $12.8M
2024 Q3 52 13.9 M $10.5M
2024 Q2 76 13.8 M $17.1M
2024 Q1 78 16.4 M $31.0M
2023 Q4 81 14.9 M $39.3M
2023 Q3 76 14.0 M $32.1M
2023 Q2 79 13.8 M $50.5M
2023 Q1 64 12.1 M $43.0M
2022 Q4 63 12.8 M $36.4M
2022 Q3 66 12.8 M $28.7M
2022 Q2 78 14.1 M $35.0M
2022 Q1 102 17.8 M $89.2M
2021 Q4 92 16.5 M $187M
2021 Q3 91 16.9 M $246M
2021 Q2 92 18.6 M $216M
2021 Q1 92 18.8 M $230M
2020 Q4 99 19.3 M $242M
2020 Q3 94 19.5 M $294M
2020 Q2 101 16.0 M $393M
2020 Q1 76 13.1 M $185M
2019 Q4 64 10.6 M $168M
2019 Q3 46 6.08 M $51.3M
2019 Q2 38 4.50 M $40.5M
2019 Q1 39 3.45 M $26.7M
2018 Q4 37 3.23 M $15.2M
2018 Q3 38 3.62 M $32.7M
2018 Q2 39 3.18 M $37.7M
2018 Q1 29 1.84 M $25.9M